SUVEMCITUG
UNII T7Y5VC4ERJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Suvemcitug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) T7Y5VC4ERJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1610010-57-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

T7Y5VC4ERJ

CAS Registry Number

1610010-57-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SUVEMCITUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C122403

National Cancer Institute reference terminology for clinical and research data.

INN ID

12428

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Suvemcitug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SUVEMCITUG

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR) (HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL APX 003 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL APX 003 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS VEGFA (VASCULAR ENDOTHELIAL GROWTH FACTOR A, VEGF-A, VEGF)), HUMANIZED MONOCLONAL ANTIBODY (GAMMA1 HEAVY CHAIN HUMANIZED (1-452) (VH (HOMO SAPIENS IGHV3-21*01 (74.7%) -(IGHD) -IGHJ2*01 (92.9%), CDR-IMGT (9.8.14) (26-34.52-59.98-111)) (1-122) -HOMO SAPIENS IGHG1*01 (100%), G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (219) (123-220), HINGE 1-15 (221-235), CH2 (236-345), CH3 D12 (361), L14 (363)(346-450), CHS (451-452)) (123-452)), (225-219')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-219') (V-KAPPA (HOMO SAPIENS IGKV1-6*01 (85.4%) -IGKJ4*01 (100%), CDR-IMGT (8.3.12) (27-34.52-54.91-102)) (1'-112') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1 (158), V101 (196)(113'-219')); DIMER (231-231'':234-234'')-BISDISULFIDE; PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA)

SEVACIZUMAB

SEVACIZUMAB [WHO-DD]

SUVEMCITUG [INN]